COVID-19 Therapeutics Strategy: Commission identifies five promising candidate therapeutics

(Credit: Unsplash)

This article is brought to you in association with the European Commission.


The EU Strategy on COVID-19 Therapeutics delivers today its first outcome, with the announcement of the first portfolio of five therapeutics that could soon be available to treat patients across the EU. Four of these therapeutics are monoclonal antibodies under rolling review by the European Medicines Agency. Another one is an immunosuppressant, which has a marketing authorisation that could be extended to include the treatment of COVID-19 patients.

Commissioner for Health and Food Safety, Stella Kyriakides, said:“Today we are taking the first step towards a broad portfolio of therapeutics to treat COVID-19. Whilst vaccination is progressing at increasing speed, the virus will not disappear and patients will need safe and effective treatments to reduce the burden of COVID-19. Our goal is clear, we aim to identify more front-runner candidates under development and authorise at least three new therapeutics by the end of the year. This is the European Health Union in action.”

The five products are in an advanced stage of development and have a high potential to be among the three new COVID-19 therapeutics to receive authorisation by October 2021, the target set under the Strategy, provided the final data demonstrate their safety, quality and efficacy. The products are:

A new COVID-19 indication for existing medicines:

  • baricitinib immunosuppresant (a medicine that reduces the activity of the immune system) from Eli Lilly: an application for extension of marketing authorisation for COVID-19 indication is under assessment

Newly developed monoclonal antibodies under rolling review – a regulatory tool to speed up the assessment of a promising medicine during a public health emergency:

  • combination of bamlanivimab and etesevimab from Eli Lilly: under rolling review
  • combination of casirivimab and imdevimab from Regeneron Pharmaceuticals, Inc. and F. Hoffman-La Roche, Ltd: under rolling review
  • regdanivimab from Celltrion: under rolling review
  • sotrovimab from GlaxoSmithKline and Vir Biotechnology, Inc.: under rolling review

Next Steps

The Commission will draw up a portfolio of at least 10 potential COVID-19 therapeutics by October, building on the work of the newly established expert group on COVID-19 variants.  The selection process will be objective and science based, with selection criteria agreed with the Member States. Since different types of products are needed for different patient populations and different stages and severity of the disease, the expert group will identify product categories and select the most promising therapeutics candidates for each category based on science based criteria. 

The portfolio will contribute to the objective of having at least three new therapeutics authorised by October and possibly two more by the end of the year. The European Medicines Agency will start more rolling reviews of promising therapeutics by end-2021, subject to research and development outcomes.

The Commission recently concluded a joint procurement of monoclonal antibodies (casirivimab and imdevimab) and could launch more by the end of the year.

The first industry matchmaking event on therapeutics will be organised on the 12-13 July to ensure that once authorised therapeutics are produced in sufficient quantity as soon as possible.

Background

The EU Strategy on COVID-19 Therapeutics aims to build a broad portfolio of COVID-19 therapeutics with the goal of having three new therapeutics available by October 2021 and possibly two more by the end of the year. It covers the full lifecycle of medicines from research, development, selection of promising candidates, fast regulatory approval, manufacturing and deployment to final use.

The Strategy forms part of a strong European Health Union, using a coordinated EU approach to better protect the health of our citizens, equip the EU and its Member States to better prevent and address future pandemics, and improve resilience of Europe’s health systems.

The Strategy, which focuses on the treatment of patients with COVID-19, works alongside the successful EU Vaccines Strategy, through which safe and effective vaccines against COVID-19 have been authorised for use in the EU to prevent and reduce transmission of cases, as well as hospitalisation rates and deaths caused by the disease.

the sting Milestones

Featured Stings

Can we feed everyone without unleashing disaster? Read on

These campaigners want to give a quarter of the UK back to nature

How to build a more resilient and inclusive global system

Stopping antimicrobial resistance would cost just USD 2 per person a year

5 challenges for government adoption of AI

A Sting Exclusive: “Sustainable development goals: what role for business?” Commissioner Mimica asks live from European Business Summit 2015

Christmas spending: Who can afford not to cut?

How teaching ‘future resilient’ skills can help workers adapt to automation

High-Level Forum on providing protection to Afghans at risk

How India is harnessing technology to lead the Fourth Industrial Revolution

It’s time to end the stigma around mental health in the workplace

Yes, together we can make a change! YO!Fest and EYE 2016

More urgency needed to help increasing numbers ‘locked out’, before 2030, says UN’s Bachelet

Climate change is forcing 20 million people a year from their homes, Oxfam says

COVID-19 has been a setback for women. Gender-responsive policies can stem the losses

Gig workers among the hardest hit by coronavirus pandemic

This Brooklyn farm company is training a new generation of urban farmers

Empathic AI could be the next stage in human evolution – if we get it right

UN chief urges emergency fund support as one of the ‘most effective investments’ in humanitarian action

LGBTQ+: The social evolution of a minority

EU job-search aid worth €9.9 million for 1,858 former Air France workers

Armed groups threaten every child in Central African Republic, UNICEF warns

Inegalitarian taxation on labour haunts Europe’s social model

Here’s how one business leader is tackling injustice: It starts with personal commitment

To my Chinese friend

UN agency warns conditions around Yemen’s key port city of Hudaydah still ‘very bad’, as staff rush to deliver aid

Commission launches debate on responding to the impact of an ageing population

Honeybees are transforming the lives of mangrove farmers in Viet Nam – here’s how

Migration crisis update: mutual actions and solidarity needed as anti-migrant policies thrive

India vs Virus: voices from the COVID front line

Coronavirus: 70% of the EU adult population fully vaccinated

Azeri natural gas will keep the EU warm soon

Black Lives Matter – for Pakistan’s Sheedi community too

Go early, go hard and keep it simple: how Senegal is staying ahead of the COVID-19 pandemic

Busting the myths about coronavirus

4 key steps to decommissioning coal-fired power plants

Coronavirus response: Team Europe supports Somalia with three EU Humanitarian Air Bridge flights

‘Huge’ stakes, ‘daunting’ job to tackle gender-based violence, UNICEF chief tells ground-breaking conference

We need tech solutions that value human interaction more than ever

European Commission adopts new tools for safe exchanges of personal data

Health Systems and Society: ways to reinforce the human power during the pandemic

Eight years after Fukushima, nuclear power is making a comeback

World Wildlife Day: UN chief urges ‘more caring’ relationship with nature

US – Russia bargain on Syria, Ukraine but EU kept out

How COVID-19 is driving a long-overdue revolution in education

Portugal: €4.66 million in aid for 1,460 dismissed workers and jobless young

‘A new chapter’ dawns for democracy in Guinea-Bissau: top UN official

Statement by Executive Vice-President Margrethe Vestager on the Commission’s proposal for a new Regulation to address distortions caused by foreign subsidies in the Single Market

5 surprising ways major cities are going green

The right approach to addressing overcapacity problem from a Chinese perspective

WEF Davos 2016 LIVE: “Chinese economy has great potential, resilience and ample space for policy adjustment”, China’s Vice President Li Yuanchao reassures from Davos

New neighbours: Could Venus really be home to alien life?

Remarks by Commissioner Virginijus Sinkevičius on the Zero Pollution Action Plan

Chart of the day: When do young Europeans leave home?

UN chief condemns attack targeting international forces in northern Mali

Emotional stability and the COVID-19 pandemic: is it possible to reconcile them?

Volkswagen scandal update: “We want clarity fast, but it is equally important to have the complete picture”, Commission’s spokesperson underscores from Brussels

Nordic noir: The unhappiness epidemic affecting young people in the world’s happiest countries

Climate change: cutting the good by the root?

Why the global trade of chemicals is key to COVID-19 recovery

What does the future of energy look like, how do we get there, and who will benefit?

Brexit: PM May must hush Boris Johnson to unlock the negotiations

Eurozone needs more than some decimals of growth

GSMA Reveals Global Partners for MWC21 Barelona

More Stings?

Speak your Mind Here

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: